Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices 46307 

reached. Requests for an opportunity to 

make a presentation from individuals or 

organizations that did not make such a 

request in advance may be granted if 

time permits. 

Persons who submit a notice of 

participation in advance of the hearing 

should check in at the on-site 

registration desk between 8 a.m. and 9 

a.m. Persons who wish to submit a 

notice of participation on-site on the 

day of the hearing may do so at the 

registration desk between 8 a.m. and 9 

a.m. We encourage all participants to 

attend the entire hearing. Because the 

hearing will be held in a Federal 

building, hearing participants must 

present photo identification and plan 

adequate time to pass through the 

security system. 

We may post all submissions and 

received comments without change to 

http://www.regulations.gov, including 

any personal information provided. 

VI. Request for Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) written or electronic 

comments for consideration at or after 

the hearing in addition to, or in place of, 

a request for an opportunity to make an 

oral presentation (see section V of this 

document). Submit a single copy of 

electronic comments or two paper 

copies of any mailed comments, except 

that individuals may submit one paper 

copy. Comments are to be identified 

with the docket number found in 

brackets in the heading of this 

document. Received comments may be 

seen in the Division of Dockets 

Management between 9 a.m. and 4 p.m., 

Monday through Friday. 

Please note that on January 15, 2008, 

the FDA Division of Dockets 

Management Web site transitioned to 

the Federal Dockets Management 

System (FDMS). FDMS is a 

Government-wide, electronic docket 

management system. Electronic 

comments or submissions will be 

accepted by FDA only through FDMS at 

http://www.regulations.gov. 

VII. Transcripts 

Please be advised that as soon as a 

transcript is available, it will be 

accessible at http://www.fda.gov/ohrms/ 

dockets/ac/acmenu.htm. It may be 

viewed at the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. A transcript 

will also be available in either hardcopy 

or on CD-ROM after submission of a 

Freedom of Information request. Written 

requests are to be sent to Division of 

Freedom of Information (HFI–35), Office 

of Management Programs, Food and 

Drug Administration, 5600 Fishers 

Lane, rm. 6–30, Rockville, MD 20857. 

VIII. References 

We have placed the following 

references on display in the Division of 

Dockets Management (see ADDRESSES) 

and interested parties may see them 

between 9 a.m. and 4 p.m., Monday 

through Friday. (FDA has verified the 

Web site addresses, but FDA is not 

responsible for any subsequent changes 

to the Web site after this document 

publishes in the Federal Register.) 

1. Center for Food Safety and Applied 

Nutrition, U.S. Food and Drug 

Administration, ‘‘Notice to Manufacturers, 

Label Declaration of Allergenic Substances in 

Foods,’’ June 10, 1996. 

2. Food and Drug Administration, 2001, 

‘‘Statement of Policy for Labeling and 

Preventing Cross-contact of Common Food 

Allergens; Compliance Policy Guide’’

accessible at http://www.fda.gov/ora/ 

compliance_ref/cpg/cpgfod/cpg555–250.htm 

3. Center for Food Safety and Applied 

Nutrition, U.S. Food and Drug 

Administration, ‘‘Report to the Committee on 

Health, Education, Labor, and Pensions, 

United States Senate and the Committee on 

Energy and Commerce, United States House 

of Representatives,’’ July 2006, accessible at 

http://www.cfsan.fda.gov/~acrobat/ 

alrgrep.pdf 

4. Verrill, Linda and Conrad J. Choinie`re. 

(2009). ‘‘Are Food Allergen Advisory 

Statements Really Warnings?: Variation in 

Consumer Preferences and Consumption 

Decisions,’’ Journal of Food Products 

Marketing. 15(2) (accepted for publication). 

5. Wogalter, M.S., M.J. Kalsher, R. Rashid, 

(1999), ‘‘Effect of Signal Word and Source 

Attribution on Judgments of Warning 

Credibility and Compliance Likelihood,’’

International Journal of Industrial 

Ergonomics. 1999 24:185–192. 

6. Hefle, S.L., T.J. Furlong, L. Niemann, H. 

Lemon-Mule, S. Sicherer, S.L. Taylor, (2007), 

‘‘Consumer Attitudes and Risks Associated 

With Packaged Foods Having Advisory 

Labeling Regarding the Presence of Peanuts,’’

Journal of Allergy and Clinical Immunology, 

120(1):171–176. 

7. Food Allergy Issues Alliance, ‘‘Food 

Allergen Labeling Guidelines,’’ May 2001. 

8. Canadian Food Inspection Agency, 

‘‘Precautionary Labelling Regarding Food 

Allergens in Pre-packaged Foods’’ September 

25, 2007, accessible at http:// 

www.inspection.gc.ca/english/fssa/invenq/ 

inform/20070925e.shtml on March 26, 2008. 

9. Australian Food and Grocery Council 

Allergen Forum, ‘‘Food Industry Guide to 

Allergen Management and Labelling,’’ 2007 

revised edition, accessible at http:// 

www.allergenbureau.net/downloads/allergenguide/Allergen_Guide_2007.pdf on March 26, 

2008. 

10. Levy, A.S., ‘‘Review of Research 

Communicating Warning Information,’’

Consumer Studies Branch, Office of 

Scientific Analysis and Support, Center for 

Food Safety and Applied Nutrition, Food and 

Drug Administration, June 1997. 

Dated: July 30, 2008. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E8–18280 Filed 8–7–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group, 

Subcommittee I—Career Development. 

Date: September 30–October 1, 2008. 

Time: 8 a.m. to 5 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza National Airport, 

1480 Crystal Drive, Arlington, VA 

22202. 

Contact Person: Sonya Roberson, PhD, 

Scientific Review Officer, Resources 

And Training Review Branch, Division 

of Extramural Activities, National 

Cancer Institute, 6116 Executive Blvd., 

Room 8109, Bethesda, MD 20892, 301–

594–1182, robersos@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group, 

Subcommittee H—Clinical Groups. 

Date: October 13–14, 2008. 

Time: 8 a.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks 

Hill Road, Bethesda, MD 20814. 

Contact Person: Timothy C. Meeker, 

MD, PhD, Scientific Review Officer, 

Resources and Training Review Branch, 

Division of Extramural Activities, 

National Cancer Institute, 6116 

Executive Boulevard, Room 8103, 

Bethesda, MD 20892, (301) 594–1279, 

meekert@mail.nih.gov. 


pwalker on PROD1PC71 with NOTICES
46308 Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices 

Name of Committee: National Cancer 

Institute Initial Review Group, 

Subcommittee G—Education. 

Date: October 23–24, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Sand Key Resort, 

1160 Gulf Blvd., Clearwater, FL 33767. 

Contact Person: Jeannette F Korczak, 

PhD, Scientific Review Officer, Review 

Training Resources Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., 

Room 8115, Bethesda, MD 20892, 301–

496–9767, korczakj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 31, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–18278 Filed 8–7–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National 

Institute of Mental Health Special 

Emphasis Panel: SBIR Phase II—Topics 

44, 53 and 55B. 

Date: August 21, 2008. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate 

contract proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Aileen Schulte, PhD, 

Scientific Review Administrator, 

Division of Extramural Activities, 

National Institute of Mental Health, 

NIH, Neuroscience Center, 6001 

Executive Blvd, Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–

1225, aschulte@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: August 1, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–18243 Filed 8–7–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Newborn Screening 

Network Coordinating Center. 

Date: August 27, 2008. 

Time: 2:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Samiyyah Manning, 

Extramural Support Assistant, Division of 

Scientific Review, National Institute of Child 

Health, and Human Development, NIH, 6100 

Executive Boulevard, Room 5B01, Bethesda, 

MD 20892–7510, (301) 435–6899, 

mannings@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: August 1, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–18248 Filed 8–7–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Deafness and Other 

Communication Disorders Advisory 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Deafness and 

Other Communication Disorders Advisory 

Council. 

Date: September 12, 2008. 

Closed: 8:30 a.m. to 10:50 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892. 

Open: 10:50 a.m. to 2:30 p.m. 

Agenda: Staff reports on divisional, 

programmatic, and special activities. 


pwalker on PROD1PC71 with NOTICES